Credit Suisse Ag Neogenomics Inc Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Neogenomics Inc stock. As of the latest transaction made, Credit Suisse Ag holds 259,253 shares of NEO stock, worth $3.52 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
259,253
Previous 255,867
1.32%
Holding current value
$3.52 Million
Previous $4.14 Million
1.55%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
128MCall Options Held
1.13MPut Options Held
232K-
Black Rock Inc. New York, NY19.9MShares$270 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$193 Million0.0% of portfolio
-
Brown Advisory Inc9.67MShares$131 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.86MShares$93.1 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$85.3 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.71B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...